View in EDS HTML Full Text PDF Full Text

Treatment outcomes with purine nucleoside analog alone or with rituximab for hairy cell leukemia at first relapse.

Saved in:
Bibliographic Details
Title: Treatment outcomes with purine nucleoside analog alone or with rituximab for hairy cell leukemia at first relapse.
Authors: Hu, Rachel1 (AUTHOR), Wei, Wei1 (AUTHOR), Mian, Agrima1 (AUTHOR), Gonter‐Aubin, Kristen2 (AUTHOR), Kabel, Charlene3 (AUTHOR), Mato, Anthony3 (AUTHOR), Stephens, Deborah M.4 (AUTHOR), Hanlon, Ashley5 (AUTHOR), Khajavian, Sirin6 (AUTHOR), Shadman, Mazyar6 (AUTHOR), Brander, Danielle5 (AUTHOR), Madanat, Yazan1 (AUTHOR), Park, Jae H.3 (AUTHOR), Tallman, Martin3 (AUTHOR), Pinilla‐Ibarz, Javier2 (AUTHOR), Hill, Brian T.1 (AUTHOR) hillb2@ccf.org
Source: European Journal of Haematology. May2022, Vol. 108 Issue 5, p379-382. 4p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09024441
DOI:10.1111/ejh.13744